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We previously identified a Neisseria flavescens strain in the duodenum of celiac dis-
ease (CD) patients that induced immune inflammation in ex vivo duodenal mucosal
explants and in CaCo‐2 cells. We also found that vesicular trafficking was delayed
after the CD‐immunogenic P31‐43 gliadin peptide‐entered CaCo‐2 cells and that
Lactobacillus paracasei CBA L74 (L. paracasei‐CBA) supernatant reduced peptide
entry. In this study, we evaluated if metabolism and trafficking was altered in CD‐
N. flavescens‐infected CaCo‐2 cells and if any alteration could be mitigated by
pretreating cells with L. paracasei‐CBA supernatant, despite the presence of P31‐
43. We measured CaCo‐2 bioenergetics by an extracellular flux analyser, N. flavescens
and P31‐43 intracellular trafficking by immunofluorescence, cellular stress by TBARS
assay, and ATP by bioluminescence. We found that CD‐N. flavescens colocalised more
than control N. flavescens with early endocytic vesicles and more escaped autophagy
thereby surviving longer in infected cells. P31‐43 increased colocalisation of
N. flavescens with early vesicles. Mitochondrial respiration was lower (P < .05) in
CD‐N. flavescens‐infected cells versus not‐treated CaCo‐2 cells, whereas pretreat-
ment with L. paracasei‐CBA reduced CD‐N. flavescens viability and improved cell bio-
energetics and trafficking. In conclusion, CD‐N. flavescens induces metabolic
imbalance in CaCo‐2 cells, and the L. paracasei‐CBA probiotic could be used to cor-
rect CD‐associated dysbiosis.
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Microbial dysbiosis has been identified in patients with active celiac dis-
ease (CD) (Girbovan, Sur, Samasca, & Lupan, 2017; Kho & Lal, 2018).
Using 16S rRNA analysis of duodenal and oropharyngeal samples from
CD patients and control subjects (Ctr), we previously identified a pecu-
liar Neisseria flavescens strain in adults affected by CD (D'Argenio et al.,
2016; Iaffaldano et al., 2018). This bacterial strain, isolated from the
above samples, induced an immune‐inflammatory response in human
and murine dendritic cells, in CaCo‐2 cells, and in ex vivo duodenal
mucosal explants of Ctr subjects, thereby suggesting that it could play
a role in CD (D'Argenio et al., 2016). Whole‐genome shotgun sequenc-
ing revealed alterations in the iron acquisition system, particularly in the
haemoglobin receptor, neisserial haptoglobin‐haemoglobin A/B, and
transferrin A/B binding protein genes in the CD associated but not in
Ctr‐N. flavescens isolates (D'Argenio et al., 2016). Furthermore, intracel-
lular trafficking between CD‐N. flavescens and Ctr‐N. flavescens isolates
was delayed in CaCo‐2 cells at the late lysosomal compartment
(D'Argenio et al., 2016). Interestingly, delay of vesicular trafficking has
also been reported after the CD‐immunogenic P31‐43 gliadin peptide
entered CaCo‐2 cells (Barone et al., 2010). CD is an autoimmune disor-
der caused by the loss of oral tolerance to gluten, in which changes of
mucosal histology results from a Th1 response to certain gliadin pep-
tides (e.g., the 33‐mer A‐gliadin peptide) presented by human leucocyte
antigen‐DQ2 or 8 (Sollid, 2000) and activation of innate immune path-
ways. Both the 33‐mer and 25‐mer (P31‐55), which contain peptides
P57‐68 and P31‐43, respectively, are very resistant to hydrolysis by
gastric, pancreatic, and intestinal proteases. Thus, these peptides are
active in vivo in the celiac intestine after gluten ingestion (Comino
et al., 2012; Marsh, 1992; Shan et al., 2002). The mechanisms by which
P31‐43 might induce the innate immune response and enterocyte pro-
liferation have been attributed to its effect on the endocytic compart-
ment (Barone, Troncone, & Auricchio, 2014; Barone & Zimmer, 2016).
In both celiac enterocytes and CaCo‐2 cells, P31‐43 localises to the
early endosomes and delays vesicular trafficking (Barone et al., 2007,
2010; Barone & Zimmer, 2016). In detail, P31‐43 shares sequence sim-
ilarity with a region of growth factor‐regulated tyrosine kinase sub-
strate (HGS), the latter is located on the membranes of early
endocytic vesicles and is a key molecule involved in regulating
endocytic maturation (Barone et al., 2010). In CaCo‐2 cells, P31‐43
interferes with the correct localisation of HGS in early endosomes
thereby delaying maturation of endocytic vesicles (Barone et al.,
2010). Thus, P31‐43 induces two important effects: (a) It delays
endocytic maturation, and (b) it alters the recycling pathway.
Furthermore, low levels of Lactobacilli are one of the most consis-
tent findings in the microbiomes of adults and children with active CD
(D'Argenio et al., 2016; Di Cagno et al., 2011; Nadal, Donat, Ribes‐
Koninckx, Calabuig, & Sanz, 2007; Nistal et al., 2012). In addition, pre-
treatment of CaCo‐2 cells with Lactobacillus paracasei CBA L74 super-
natant (L. paracasei‐CBA) reduced the entry of gliadin peptides in the
cell, thereby decreasing their toxicity (Sarno et al., 2014).
In this scenario, we evaluated (a) if parallel to the inflammatory
response, CD‐N. flavescens‐associated dysbiosis induces changes inCaCo‐2 bioenergetics (measured by extracellular flux analyser: XF),
thereby concurring to exacerbate the epithelial intestinal cell malfunc-
tion; (b) if the immunogenic P31‐43 peptide interferes with the intra-
cellular CD‐N. flavescens pathway; and (c) if pretreatment of CaCo‐2
cells with the L. paracasei‐CBA supernatant could mitigate any of the
effects exerted by CD‐N. flavescens‐associated dysbiosis on the
CaCo‐2 cells, notwithstanding the presence of the P31‐43 peptide.2 | RESULTS
2.1 | CD‐N. flavescens and Ctr‐N. flavescens
localisation in the early, late, and autophagosomal
vesicular compartments
We previously reported preliminary data showing that intracellular
trafficking of CD‐N. flavescens differs from that of Ctr‐N. flavescens
in CaCo‐2 cells (D'Argenio et al., 2016). One of the aims of the
present study was to verify and extend the intracellular trafficking of
N. flavescens. To this aim, we investigated the localisation of CD‐
N. flavescens and Ctr‐N. flavescens in the early, late, and
autophagosomal compartments of CaCo‐2 cells by immunofluores-
cence. We found that colocalisation of CD‐N. flavescens and early
endosome antigen 1 (EEA1), a marker of the early endocytic compart-
ment, was significantly greater than that of Ctr‐N. flavescens
(P < .0001; Figure 1). Notably, significantly (P < .01) fewer CD‐
N. flavescens bacteria than Ctr‐N. flavescens bacteria localised to the
late anti‐lysosomal‐associated membrane protein‐2 (LAMP‐2) positive
vesicles (Figure S1), which is in line with our previous finding
(D'Argenio et al., 2016). Furthermore, using the microtubule‐
associated proteins 1A/1B light chain 3B (LC3) vesicle marker, we
investigated the localisation of CD‐N. flavescens and Ctr‐N. flavescens
bacteria in the autophagosomal compartment using immunofluores-
cence. As shown in Figure 2, CD‐N. flavescens and LC3 colocalisation
was significantly lower (P < .01) than that of Ctr‐N. flavescens. Our
data indicate that, unlike Ctr‐N. flavescens, CD‐N. flavescens preferen-
tially localised to the early vesicular compartment and was able to
elude the autophagosomal compartment.2.2 | Effect of the P31‐43 gliadin peptide on the
localisation of CD‐N. flavescens and Ctr‐N. flavescens in
the early, late, and autophagosomal vesicular
compartments
To determine if and how the P31‐43 gliadin peptide interferes with
bacterial endocytosis, we infected CaCo‐2 cells with CD‐N. flavescens
and Ctr‐N. flavescens and treated them with the toxic P31‐43 peptide.
We used this gliadin peptide for two reasons: (a) It is resistant to intes-
tinal endopeptidases and is thus active in the intestinal mucosa
(Nanayakkara et al., 2018), and (b) it delays vesicular trafficking in
intestinal epithelial cells (Barone et al., 2007). As shown in Figure 3a,
b, P31‐43 significantly decreased (P < .05) the colocalisation of CD‐
N. flavescens and Ctr‐N. flavescens in the late compartment and
FIGURE 1 Celiac disease (CD)‐Neisseria flavescens colocalised more with early endosome antigen 1 (EEA1) than control (Ctr)‐N. flavescens. (a)
Fluorescence images of CaCo2 cells infected with CD‐N. flavescens and Ctr‐N. flavescens. CD‐N. flavescens and Ctr‐N. flavescens are shown in
green; EEA1 is shown in red and yellow indicated colocalisation. (b) Statistical analysis of the EEA1/CD‐N. flavescens or Ctr‐N. flavescens
colocalisation in CaCo‐2 cells. The experiments were replicated 9 times. The columns and bars represent the mean and standard deviation.
Student's t test ****P < .0001
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colocalisation in the early compartment (Figure 3c,d), thereby globally
increasing the N. flavescens content in the early compartment. More-
over, the P31‐43 peptide significantly increased the level of
CD‐N. flavescens and Ctr‐N. flavescens in the autophagosomal com-
partment (P < .001 and P < .05, respectively; Figure 3e,f).
2.3 | Effect of pretreatment with L. paracasei‐CBA
probiotic supernatant on the entry, viability, and
intracellular localisation of CD‐N. flavescens and Ctr‐
N. flavescens in CaCo‐2 cells in the presence and
absence of P31‐43
We asked whether pretreatment of cells with L. paracasei‐CBA
supernatant could in some way counteract the effect of CD‐associated dysbiosis in CaCo‐2 cells, notwithstanding the presence
of the P31‐43 peptide. The rationale of this experiment was based
on several reasons: (a) low levels of Lactobacilli have been reported
in active CD patients (D'Argenio et al., 2016; Di Cagno et al., 2011;
Nadal et al., 2007; Nistal et al., 2012), (b) lower faecal levels of Lac-
tobacillus in active CD patients than in controls have been associated
with differences in gluten metabolism between the two groups of
individuals (Caminero et al., 2015), (c) experimental evidence
obtained by our group indicated that the pretreatment of CaCo‐2
cells with L. paracasei‐CBA supernatant reduced the entry of gliadin
peptides into the cell, thereby decreasing their toxicity (Sarno et al.,
2014),
Using immunofluorescence, we tested whether L. paracasei‐CBA
supernatant could affect the entry of N. flavescens bacteria into
CaCo‐2 cells. As shown in Figure 2a,b CD‐N. flavescens levels were
FIGURE 2 Celiac disease (CD)‐Neisseria flavescens colocalised less with light chain 3B (LC3) than controll (Ctr)‐N. flavescens. (a) Fluorescence
images of CaCo‐2 cells infected with CD‐N. flavescens and Ctr‐N. flavescens. CD‐N. flavescens and Ctr‐N. flavescens are shown in green; LC3 is
shown in red and yellow indicated colocalisation. (b) Statistical analysis of the LC3/CD‐N. flavescens or Ctr‐N. flavescens colocalisation in CaCo‐2
cells. The experiments were replicated 9 times. The columns and bars represent the mean and standard deviation. Student's t test **P < .01
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CaCo‐2 cells 1 hr after infection. We verified bacteria viability by eval-
uating viable bacteria count in CaCo‐2 N. flavescens‐infected cell
lysates (Figure S2c,d). Notably, the probiotic supernatant did not sig-
nificantly affect the entry of bacterium into the cells but reduced its
viability (Figure S2a–g). Pretreatment with L. paracasei‐CBA increased
the colocalisation of CD‐N. flavescens with LAMP‐2 and decreased the
colocation with EEA1 (Figure 4a,c; P < .01 and P < .0001, respectively)
but did not significantly affect intracellular Ctr‐N. flavescens
colocalisation (Figure 4b,d). No change in the intracellular trafficking
of N. flavescens bacteria was observed after the addition of the P31‐
43 toxic peptide to CaCo‐2 cells pretreated with L. paracasei‐CBA
(Figure 4a–d).2.4 | Metabolic phenotype of untreated CaCo‐2 cells
and of N. flavescens‐infected CaCo‐2 cells analysed
before and after exposure to various treatments
We previously showed that N. flavescens isolated from duodenal and
oropharyngeal samples of active CD patients triggered an immune‐
inflammatory reaction in mucosal duodenal explants and in CaCo‐2
cells (D'Argenio et al., 2016). In the present study, we asked if, parallel
to the inflammatory response, N. flavescens induces changes in the
CaCo‐2 bioenergetics (measured using an extracellular flux analyser:
XF) and thus concurs to exacerbate the epithelial intestinal cell mal-
function. To this end, we investigated metabolic phenotypes, in terms
of glycolysis and oxidative phosphorylation, in NT and
FIGURE 3 P31‐43 peptide treatment decreased celiac disease (CD)‐Neisseria flavescens and control (Ctr)‐N. flavescens localisation in the late
compartment and increased that in the early endosomal and autophagosomal compartments, respectively. Fluorescence images of CaCo‐2 cells
infected with CD‐N. flavescens or Ctr‐N. flavescens after treatment with P31‐43. CD‐N. flavescens and Ctr‐N. flavescens are shown in green, (a) anti‐
lysosomal‐associated membrane protein‐2 (LAMP‐2), (c) early endosome antigen 1 (EEA1), and (e) light chain 3B (LC3) are shown in red; yellow
indicates colocalisation. Statistical analysis of (b) LAMP‐2, (d) EEA1, and (f) LC3 colocalisation of CD‐N. flavescens and Ctr‐N. flavescens in CaCo‐2
cells after treatment with peptide P31‐43. The columns and bars represent mean and standard deviation. The experiments were replicated 6 times
(LAMP‐2, EEA1) or 4 times (LC3). Student's t test *P < .05, **P < .01, ***P < .001, ****P < .0001
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pared with the metabolic phenotypes obtained in CaCo‐2 cells after
each of the following treatments: pretreatment with L. paracasei‐
CBA, addition of P31‐43, CD‐N. flavescens/P31‐43, L. paracasei‐
CBA/CD‐N. flavescens, or L. paracasei‐CBA/CD‐N. flavescens/P31‐43
(Figures S3 and 5). Globally, we found that both glycolytic perfor-
mance and oxidative phosphorylation (an indicator of mitochondrial
respiratory capacity) were significantly lower in CD‐N. flavescens‐
infected CaCo‐2 cells than in either treated or NT cells (P < .05; Figure
S3a,b). In detail, basal glycolysis, measured by extracellular acidifica-
tion rate (ECAR; Figure 5a), was lower, albeit not significantly so, in
CD‐N. flavescens‐infected CaCo‐2 cells than in NT cells (ECAR, Cd‐
N. flavescens = 12.3 ± 1.7 mpH/min vs. NT = 16.5 ± 1.4 mpH/min),
whereas it was significantly lower (P < .05) in CD‐N. flavescens‐
infected cells than in either L. paracasei‐CBA or L. paracasei‐CBA/
CD‐N. flavescens/P31‐43‐treated CaCo‐2 cells (ECAR,
23.3 ± 2.3 mpH/min). Moreover, basal glycolysis did not differ
between NT and P31‐43‐treated CaCo‐2 cells (ECAR,
17.7 ± 1.3 mpH/min) and was significantly lower in NT than in
L. paracasei‐CBA‐treated CaCo‐2 cells (ECAR, 22.2 ± 1.4 mpH/min,
P < .05; Figure 5a).The glycolytic reserve, which represents the difference between
maximal glycolysis post‐oligomycin addition and basal glycolysis
(Figure 5b), was similar in CD‐N. flavescens‐infected cells and NT cells,
whereas it exceeded NT values in CaCo‐2 cells exposed to any of the
other treatments tested (P < .05). Glycolytic capacity, which repre-
sents the maximum glycolytic rate, was significantly lower in
CD‐N. flavescens‐infected CaCo‐2 cells than in NT cells or in cells
exposed to any other treatment tested (P < .05; Figure S3A).
Mitochondrial activity, which is basal respiration measured by
Oxygen Consumption Rate (OCR; Figure 5C), was significantly lower
in CD‐N. flavescens‐infected cells than in NT CaCo‐2 cells (OCR,
CaCo‐2/CD‐N. flavescens = 49.4 ± 1.7 pmol/min,
NT = 102.1 ± 1.6 pmol/min, P < .05) and in cells exposed to other
treatment: L. paracasei‐CBA (OCR, 82.6 ± 6.3 pmol/min, P < .05),
P31‐43 (OCR, 103.4 ± 1.5 pmol/min, P < .05), CD‐N. flavescens/
P31‐43 (OCR, 94.2 ± 1.6 pmol/min, P < .05), L. paracasei‐CBA/Cd‐
N. flavescens (OCR, 85.0 ± 2.2 pmol/min, P < .05), and L. paracasei‐
CBA/CD‐N. flavescens/P31‐43 (OCR, 74.3 ± 1.8 pmol/min, P < .05).
Uncoupled mitochondrial activity (i.e., OCR post‐FCCP—OCR
Ant/Rot) is reported in Figure S4. Spare respiratory capacity
(Figure 5d), which represents the difference between maximal
FIGURE 4 Lactobacillus paracasei CBA L74 (L. paracasei‐CBA) increased celiac disease (CD)‐Neisseria flavescens colocalisation with anti‐
lysosomal‐associated membrane protein‐2 (LAMP‐2), whereas it reduced that with early endosome antigen 1 (EEA1) in presence of the P31‐43
gliadin peptide. Statistical analysis of the colocalisation of CD‐N. flavescens and control (Ctr)‐N. flavescens with LAMP‐2 (a, b, respectively) and
EEA1 (c, d, respectively) in cells pretreated with L. paracasei‐CBA in the absence and presence of the P31‐43 peptide. The columns and bars
represent mean and standard deviation. The experiments were replicated 3 times. Student's t test *P < .05, **P < .01, ***P < .001, ****P < .0001
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among NT, CD‐N. flavescens‐infected and L. paracasei‐CBA
pretreated CaCo‐2 cells, whereas it was significantly higher
(P < .05) in cells treated with the P31‐43 immunogenic peptide than
in NT cells. Similar results were obtained in Ctr‐N. flavescens‐infected
CaCo2 cells (data not shown). We also calculated the ECAR/OCR
ratio (Figure 5e), which is an indicator of the relative utilisation of
glycolysis and oxidative phosphorylation, in each of the six experi-
mental conditions included in this study and in NT cells. The
ECAR/OCR ratio was significantly higher in CD‐N. flavescens‐infected
CaCo‐2 cells than in NT cells (0.25 ± 0.03 vs. 0.16 ± 0.01 mpH/pmol,
P < .05). It was also significantly higher in L. paracasei‐CBA and in
L. paracasei‐CBA/CD‐N. flavescens/P31‐43‐treated CaCo2 cells than
in NT cells (P < .05). On the contrary, the ECAR/OCR ratio did not
differ between NT and P31‐43‐treated cells (Figure 5e).
Globally, our data indicate that, after N. flavescens infection, the
bioenergetics metabolism in CaCo‐2 epithelial cells is less efficient
than in NT cells and is characterised by a significant decrease in oxida-
tive phosphorylation activity. This effect was not observed in
N. flavescens‐infected CaCo‐2 cells exposed to the P31‐43 toxic pep-
tide or in cells pretreated with the L. paracasei‐CBA supernatant.2.5 | Measurement of oxidative stress and ATP
content in CaCo‐2 cells after N. flavescens infection
and effect of pretreatment with L. paracasei
supernatant
To quantify oxidative stress in N. flavescens‐infected cells and to test
the efficacy of cellular pretreatment with L. paracasei‐CBA superna-
tant in reducing it, we measured malondialdehyde (MDA) level, which
is an indicator of cellular oxidative stress. MDA content increased
from 3.2 μM in NT CaCo‐2 cells up to 10.0 μM in CD‐N. flavescens‐
infected CaCo‐2 cells, which indicates that bacterial infection caused
an increase in cellular oxidative stress (Figure S5). Interestingly, in
CaCo‐2 cells pretreated with L. paracasei‐CBA supernatant, cellular
stress after CD‐N. flavescens infection was lower than in NT cells
(MDA = 5.8 μM; Figure S5a). These results indicate that the
L. paracasei‐CBA supernatant is able to reduce by about 50% the cel-
lular stress associated with N. flavescens infection.
We then evaluated whether the significant decrease in cellular oxi-
dative phosphorylation (mitochondrial activity) caused by the bacterial
infection was paralleled by a change in ATP production and whether
the pretreatment of cells with L. paracasei‐CBA supernatant affected
FIGURE 5 Metabolic phenotype of not treated and of differently treated CaCo‐2 cells. Bioenergetics profiles in not treated CaCo‐2 (NT) cells
and in CaCo‐2 cells cocultured with: celiac disease (CD)‐Neisseria flavescens; Lactobacillus paracasei CBA L74 (L. paracasei‐CBA); P31‐43
peptide; CD‐N. flavescens/P31‐43; L. paracasei‐CBA/CD‐N. flavescens; L. paracasei‐CBA/CD‐N. flavescens/P31‐43. (a) Basal glycolysis extracellular
acidification rate (ECAR; (measured as the difference between post‐glucose addition ECAR and non‐glycolytic ECAR). (b) Glycolytic reserve
(measured as the difference between maximal glycolysis postoligomycin addition and basal glycolysis). (c) Basal respiration oxygen consumption
rate (OCR; measured as the difference between preoligomycin addition and nonmitochondrial respiration). (d) Spare respiratory capacity
(measured as the difference between maximal respiration post‐FCCP addition and basal respiration). (e) ECAR/OCR ratio, a measure of cell relative
utilisation of glycolysis and oxidative phosphorylation. Data are expressed as mean ± SEM. Data comparison between groups was performed using
the Kruskal–Wallis test. *Statistically significant differences (P < .05) after Bonferroni correction between groups encompassed by the bar.
#Statistically significant differences (P < .05) after Bonferroni correction between the highlighted group and each of the other tested conditions
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N. flavescens‐infected CaCo‐2 cells pretreated or not with L. paracasei‐
CBA supernatant. The ATP level was 91.1 nM in NT CaCo‐2 cells and
decreased to 66.4 nM in N. flavescens‐infected CaCo‐2 cells. A similar
reduction occurred in N. flavescens‐infected CaCo‐2 cells pretreated
with L. paracasei CBA supernatant (45.5 nM; Figure S5b). This result
suggests that, although the L. paracasei‐CBA supernatant reduces
the viable bacterial load, mitochondrial activity was still damaged and
that metabolism probably shifted versus glucose conversion to lactate.
Given the low number of samples tested in each experimental condi-
tion (n = 2), we were unable to obtain a statistically significant differ-
ence with the ANOVA test.3 | DISCUSSION
The aims of this study were to investigate (a) if, parallel to the inflam-
matory response, the N. flavescens strain, which is increased in duode-
nal and oropharyngeal samples from active celiac patients (D'Argenioet al., 2016; Iaffaldano et al., 2018), induces changes in the CaCo‐2
bioenergetics thus concurring to exacerbate the epithelial intestinal
cell malfunction; (b) if the intracellular trafficking of N. flavescens and
the immunogenic P31‐43 peptide could influence each other; and (c)
if the pretreatment of CaCo‐2 cells with the L. paracasei‐CBA superna-
tant could modify the effect of CD‐N. flavescens‐associated dysbiosis
on the cell, despite the presence of the P31‐43 peptide.
Mitochondrial oxidative phosphorylation was significantly reduced
in CD‐N. flavescens‐infected CaCo‐2 cells versus NT cells, which
together with the significantly increased ECAR/OCR ratio, suggested
a shift in CD‐N. flavescens‐infected CaCo‐2 cell metabolism towards
a more glycolytic phenotype. Glycolysis and mitochondrial oxidative
phosphorylation are two important ATP‐generating pathways used
to meet energy cell demand in physiological conditions (Kramer, Ravi,
Chacko, Johnson, & Darley‐Usmar, 2014). The metabolic switch from
oxidative phosphorylation to glycolysis has been described in various
cell types and conditions (Kramer et al., 2014). Notably, it was found
to provide ATP and thus to maintain mitochondrial membrane poten-
tial in monocyte–macrophage cells during inflammation (O'Neill &
8 of 12 LABRUNA ET AL.Hardie, 2013). Furthermore, glycolytic reprogramming in the host
response to bacteria has been described in Mycobacterium tuberculo-
sis‐infected murine lungs (Shi et al., 2015) and was found to be
required for inflammatory cytokine production (Braverman, Sogi, Ben-
jamin, Nomura, & Stanley, 2016). Hansen et al. (2018) recently
described bacteria‐induced conversion of a tolerogenic to an inflam-
matory response in human intestinal CD103+ dendritic cells and found
that cytokine production depended on glycolytic reprogramming that
mediated the upregulation of cytokine translation. Given that
N. flavescens isolates induce inflammatory cytokine secretion in
CaCo‐2 cells, and in murine and human CD103+ dendritic cells
(D'Argenio et al., 2016), it is feasible that glycolytic reprogramming
could occur in our experimental epithelial system. Inhibition of oxida-
tive phosphorylation was reported to increase cell production of reac-
tive oxygen species that exert bactericidal activities (O'Neill & Hardie,
2013). In agreement with that finding, we found higher levels of MDA,
which is an indicator of cellular stress, in N. flavescens‐infected CaCo‐2
cells than in NT CaCo‐2 cells. Alteration of oxidative metabolism was
also supported by the decrease in ATP intracellular content in
CD‐N. flavescens‐infected CaCo‐2 cells versus NT CaCo‐2 cells. Con-
sequently, it is likely that Neisseria infection induces bactericidal activ-
ity in CaCo‐2 cells also through this mechanism. In this context, it is
interesting to recall that iron perturbation at intestinal epithelial cell
level can negatively impact mitochondrial function (Paul, Manz, Torti,
& Torti, 2017) and that competition for iron is a key aspect of infec-
tious diseases (Caza & Kronstad, 2013). Consequently, it is tempting
to speculate that the genetic differences in the iron acquisition system
that we previously demonstrated between CD‐associated N. flavescens
and the Ctr‐N. flavescens (D'Argenio et al., 2016) could also concur to
the mitochondrial dysfunction observed in this study.
Despite the presence of the P31‐43 peptide, pretreatment of
CaCo‐2 cells with L. paracasei‐CBA supernatant appeared to improve
cellular bioenergetics after N. flavescens‐infection likely due to the
probiotic's ability to reduce bacterial viability. Notably, in
L. paracasei‐CBA pretreated CD‐N. flavescens‐infected CaCo‐2 cells,
we observed the recovery of glycolysis (glycolytic reserve) and only
a partial improvement of mitochondrial respiration as shown by the
decrease in MDA production but not yet complete recovery of ATP
production. In agreement with our data, and in the context of the gen-
eral balance of cellular energy metabolism, an increase of lactate pro-
duction was previously observed when cells tried to compensate ATP
loss, which is indicative of damaged oxidative metabolism (i.e., respira-
tion; Vander Heiden & De Berardinis, 2017).
The localization experiments of CD‐N. flavescens and Ctr‐
N. flavescens in intestinal CaCo‐2 epithelial cells demonstrated that,
after entering the cell, unlike Ctr‐N. flavescens, the presence of CD‐
N. flavescens was higher in the early endocytic compartment than in
the late endocytic compartment, which confirms and extends our pre-
vious finding (D'Argenio et al., 2016). Although we observed only
modest increases in the presence of the CD‐associated N. flavescens
in the early endocytic compartment, we and others previously
showed that similar alterations could influence several cell functions,
ranging from proliferation to actin organisation, cell motility, andstress/innate immunity activation (Barone et al., 2007; Barone et al.,
2010; Caldieri, Malabarba, Di Fiore, & Sigismund, 2018; De Matteis
& Luini, 2011; Nanayakkara et al., 2013; Nanayakkara et al., 2018;
Raiborg, Malerød, Pedersen, & Stenmark, 2008; Scita & Di Fiore,
2010; Siegert et al., 2018; Vicinanza et al., 2011). The intracellular
location of CD‐N. flavescens is in agreement with the finding that path-
ogenic Neisseria meningitidis is internalised and creates a replicative
niche within the intracellular membranous vacuoles (Barrile et al.,
2015). In addition, as autophagy is a fundamental host response to
invasion by a variety of bacterial pathogens (Randow & Youle, 2014),
we investigated whether intracellular N. flavescens is directed to
phagosomes for destruction or whether it eludes autophagy‐mediated
killing. We observed that CD‐N. flavescens colocalises less than
Ctr‐N. flavescens with the autophagy marker LC3. This finding indi-
cates that CD‐N. flavescens escapes the autophagy process, probably
by “taking refuge” in the early compartment. Accordingly, Neissera
gonorrhoeae has recently been reported to escape early autophagy‐
mediated killing by inhibiting autophagosome maturation and lyso-
some fusion (Lu et al., 2018). Similar to CD‐N. flavescens intracellular
behaviour was also described in pathogenic N. meningitidis and
Neissera gonorrhoeae (Barrile et al., 2015; Lu et al., 2018). Indeed, by
subverting intracellular trafficking, which is one of the main survival
mechanisms of human pathogens (Barrile et al., 2015; Sullivan, Young,
McCann, & Braunstein, 2012; Zhang et al., 2018), CD‐N. flavescens is
more able to escape killing and survive in intestinal cells than Ctr‐N.
flavescens.
Given the above, we investigated if the addition of the P31‐43
toxic gliadin peptide could influence the intracellular trafficking of
CD‐N. flavescens and Ctr‐N. flavescens. The treatment of
N. flavescens‐infected CaCo‐2 cells with the P31‐43 peptide increased
the colocalisation of N. flavescens strains with the EEA1 marker, which
confirms that P31‐43 can delay vesicular trafficking irrespective of the
vesicle cargo. It is conceivable that N. flavescens strains and the P31‐
43 peptide cooperate to delay endocytic trafficking at the level of
the early compartment thereby providing a “comfort zone” to enable
bacteria to survive longer in the cells. Notably, P31‐43 increased the
colocalisation of the N. flavescens isolates with LC3‐positive vesicles,
but not with LAMP‐2‐positive compartments, which suggests that also
LC3 vesicles cannot reach the late degradative vesicles. In this context,
it is feasible that P31‐43 causes LC3 vesicles to increase their fusion
with the EEA1‐positive compartment (Barone, manuscript in prepara-
tion). We also show that, although L. paracasei‐CBA probiotic superna-
tant did not alter entry of the bacteria into the cell, it reduced the
bacterium viability. Furthermore, L. paracasei‐CBA probiotic superna-
tant significantly reduced and increased the colocalisation of CD‐
N. flavescens with EEA1 and with LAMP‐2 markers, respectively,
despite the presence of the P31‐43 peptide. As pretreatment of
CaCo‐2 epithelial cells with L. paracasei‐CBA probiotic can prevent
entry of the P31‐43 gliadin peptide into cells (Sarno et al., 2014), it
is likely that this effect also impacts on the intracellular localization
of the N. flavescens strain. Moreover, alterations of trafficking similar
to those we found have been associated with or have been reported
to directly cause, changes in signalling pathways (Scita & Di Fiore,
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lier findings together with our results may help to shed light on the
disease pathology.
In conclusion, the N. flavescens strain that we identified in duode-
num and oropharyngeal samples from patients with active CD
(D'Argenio et al., 2016; Iaffaldano et al., 2018), induces imbalance in
the mitochondrial respiration of CaCo‐2 epithelial cells in parallel to
the inflammation‐immune response. This metabolic alteration appears
to be in part reversed by the probiotic L. paracasei‐CBA, irrespective
of the presence of the P31‐43 peptide. Although our data obtained
in cultured cells cannot be extrapolated to the duodenal epithelium,
they are compatible with an additional mechanism through which
CD‐N. flavescens could concur to the malfunction of the intestinal epi-
thelium in CD patients and suggests that the L. paracasei‐CBA probi-
otic could be used to correct CD‐associated dysbiosis.4 | EXPERIMENTAL PROCEDURES
4.1 | Cellular and bacterial growth conditions
CaCo‐2 cells were grown for 5 or 6 days in Dulbecco's modified
Eagle's medium (DMEM; GIBCO, San Giuliano Milanese, Italy) supple-
mented with 10% fetal calf serum (FCS, GIBCO), 100 units/ml of
penicillin–streptomycin (GIBCO), and 1‐mM glutamine (GIBCO). The
medium was changed every 2 days. The N. flavescens strains were iso-
lated as previously described (D'Argenio et al., 2016) from the duode-
num of CD patients and from the oropharynx of a healthy control
subject and were used at a multiplicity of infection of 1:100. We used
L. paracasei‐CBA isolated from the faeces of healthy newborn children
and previously tested for its anti‐inflammatory capacity (International
Depository Accession Number LMG P‐24778; Zagato et al., 2014).
To prepare the probiotic supernatant, we cultivated L. paracasei‐CBA
L74 in DMEM supplemented with 10% fetal calf serum (FCS, GIBCO),
and 1‐mM glutamine (GIBCO) until 109 CFU/ml as previously
described (Sarno et al., 2014). The bacterial culture was then centri-
fuged at 3,000 rpm for 10 min and the supernatant was filtered
through a 0‐ to 22‐micron filter. When required, lipopolysaccharide‐
free synthetic P31‐43 peptides (Inbios, Naples, Italy; >95% pure, eval-
uated by matrix‐assisted laser desorption/ionisation time‐of‐flight
mass spectrometry) were added to cell cultures. The peptides were
obtained using Ultrasart‐D20 filtration (Sartorius AG, Gottingen, Ger-
many). The level of lipopolysaccharide in these peptides was below
the detection threshold (i.e., <0.20 EU/mg), as assessed using the
QCL‐1000 kit (Cambrex Corporation, NJ, USA). The sequence of
P31‐43 was LGQQQPFPPQQPY. The peptides were used at a con-
centration of 100 μg/ml (Nanayakkara et al., 2018).4.2 | Intracellular localization of N. flavescens in
CaCo‐2 epithelial cells
CaCo‐2 cells were seeded on glass coverslips for 2 days. The cells
(1 × 105) were then infected with bacteria for 1 hr at MOI 1:100. Aftertreatment with gentamicin (100 μg/ml) for 30 min to kill extracellular
bacteria, the coverslips were washed, and 6 hr later, they were fixed
with 3% paraformaldeide for 5 min at room temperature and
permeabilised with Triton (Biorad, Milan, Italy) 0.2% for 5 min at room
temperature. They were then stained for 1 hr at room temperature
with rabbit polyclonal anti‐N. meningitidis antibody (Virostat 6121,
BD Pharmigen, Milan, Italy). Secondary antibodies conjugated
(Invitrogen, Milan, Italy) anti‐rabbit Alexa‐488 for Neisseria were
added to the coverslips for 1 hr at room temperature. The coverslips
were then mounted on glass slides and observed with a confocal
microscope (LSM 510 Zeiss, Milan, Italy) to obtain images (Figure S6,
point 1); 20–30 cells were observed in each sample. Fluorescence
analysis was performed with AIS Zeiss software. Magnification of
the micrographs was 63× objective, 2× zoom in all figures.4.3 | EEA1, LAMP‐2 or LC3 immunofluorescence
staining
The CaCo‐2 cells were infected with the bacteria as described above
(Figure S6, point 1). P31‐43 was added to the cells during the 6 hr
before fixation (Figure S6, point 2). Probiotic supernatant was added
before CD‐N. flavescens or Ctr‐N. flavescens infection (Figure S6,
points 3 and 4). Subsequently, cells were stained for 1 hr at room tem-
perature with anti‐ EEA1 or LAMP‐2 or microtubule‐associated pro-
teins 1A/1B LC3 antibodies, and with anti‐Neisseria antibodies.
Secondary antibodies conjugated anti‐rabbit Alexa‐488 for Neisseria;
anti‐goat Alexa‐546 (Invitrogen, Milan, Italy) for EEA1; anti‐mouse
Alexa‐546 (Invitrogen, Milan, Italy) for LAMP‐2; and anti‐mouse
Alexa‐546 (Invitrogen, Milan, Italy) for LC3 were added to the cover-
slips for 1 hr at room temperature. The coverslips were then mounted
on glass slides and observed with a confocal microscope; 20–30 cells
were observed in each sample. Images were examined with a Zeiss
LSM 510 laser scanning confocal microscope.4.4 | Colocalisation analysis
Colocalisation analysis was performed with AIS Zeiss software. Mag-
nification of the micrographs was 63× objective, 2× zoom in all. We
used Argon/2 (458, 477, 488, 514 nm), HeNe1 (543 nm), and
HeNe2 (633 nm) excitation lasers, which were switched on sepa-
rately to reduce cross‐talk of the three fluorochromes. The green
and the red emissions were separated by a dichroic splitter (FT
560) and filtered (515‐ to 540‐nm band‐pass filter for green and
>610‐nm long pass filter for red emission). A threshold was applied
to the images to exclude about 99% of the signal found in control
images. The weighted colocalisation coefficient represents the sum
of intensity of colocalising pixels in Channels 1 and 2 compared with
the overall sum of pixel intensities above threshold. This value could
be 0 (no colocalisation) or 1 (all pixels colocalise). Bright pixels con-
tribute more than faint pixels. The colocalisation coefficient repre-
sents the weighted colocalisation coefficient of Ch1 (red) with
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mermann et al., 2014).4.5 | CaCo‐2 bioenergetics profiling by extracellular
flux analysis
The ECAR and the OCR, which are indicators of glycolysis and mito-
chondrial respiration, respectively, were measured using the Seahorse
XFe96 extracellular flux analyser (Seahorse Bioscience, Agilent Tech-
nologies, Santa Clara, CA, USA), which carries a fluorescent probe.
The controls were represented by the cell‐free culture medium and
by not treated CaCo‐2 cells. For each tested experimental condition,
cells were plated in three wells on Seahorse 96‐well plates 24 hr
before the experiment at a density of 8 × 103 cells/well. Immediately
before the experiment, medium was replaced as follows: For OCR, we
used the XF medium (nonbuffered DMEMmedium, containing 10‐mM
glucose, 2‐mM L‐glutamine, and 1‐mM sodium pyruvate), under basal
conditions and in response to 1‐μM oligomycin (Olig–ATP synthase
inhibitor), 1‐μM carbonylcyanide‐4‐(trifluoromethoxy)‐
phenylhydrazone (FCCP—mitochondrial uncoupling), and 1‐μM
antimycin A (ant—complex III inhibitor), and rotenone (Rot—Complex
1 inhibitor); for ECAR, we used the glucose‐depleted XF medium in
basal condition and in response to 10‐mM glucose, 1‐μM oligomycin,
and 50‐mM 2‐deoxy‐D‐glucose (2‐DG—glycolysis inhibitor). In basal
conditions and after the injection of each stimulant or inhibitor chem-
ical additive, the instrumentation measures changes in oxygen concen-
tration (OCR, pmol/min) and in pH (ECAR, mpH/min) three times
(about every 10 min). Based on the average of the three measure-
ments, we calculated for the mitochondrial respiration: basal respira-
tion (OCRpre‐Olig − OCRpost‐Ant/Rot) and spare respiratory capacity
([OCRpost‐FCCP − OCRpost‐Ant/Rot] − basal respiration); for glycolysis:
basal glycolysis (ECARpre‐Olig − ECARpre‐Glucose), glycolytic reserve
([ECARpost‐Olig − ECARpre‐Glucose] − basal glycolysis). Furthermore, we
calculated the ECAR/OCR ratio as cell relative utilisation of glycolysis
and oxidative phosphorylation.4.6 | Measurement of CaCo‐2 oxidative status and
ATP production
The oxidative stress of CaCo‐2 cells was evaluated by measuring the
MDA content of cells with a colorimetric method using the TBARS
assay kit (Cayman chemical, Ann Arbor, MI, USA) according to the
manufacturer's instruction. MDA is the end product of lipid peroxida-
tion, an indicator of oxidative stress in cells, and tissue. ATP was mea-
sured with a bioluminescence assay ATP kit (Thermo Fisher Scientific,
Waltham, MA USA). Both determinations were performed in duplicate
in the following groups of cells: NT CaCo‐2 cells, CD‐N. flavescens
infected CaCo‐2 cells, L. paracasei supernatant pretreated
CD‐N. flavescens infected CaCo‐2 cells. Briefly, 2 × 107 cells were col-
lected in duplicate for every tested condition and resuspended in
150‐μL PBS before sonication; 100 μL were used for MDAdetermination, whereas 30 μL were used for ATP measurement,
according manufacturer's instructions.
4.7 | Statistical analysis
Data are expressed as mean ± SD or SEM as appropriate. Data com-
parison between groups was performed using the Kruskal–Wallis test,
Student's t test, ANOVA, or χ2 test, as appropriate. Differences were
considered statistically significant with a P < .05 after Bonferroni cor-
rection. Statistical analyses were carried out with the PASW package
for Windows (ver.18; SPSS Inc. Headquarters, Chicago, IL).
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